The chemical substance known as (5R)-6,7-Dihydro-4-[[trans-4-(4-morpholinyl)cyclohexyl]oxy]-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine-5-acetamide, with the CAS number 1388894-17-4, is characterized by its complex molecular structure, which includes a thieno[2,3-d]pyrimidine core fused with a cyclopenta ring. This compound features a morpholine moiety, contributing to its potential biological activity, particularly in medicinal chemistry. The presence of the acetamide functional group suggests possible interactions with biological targets, making it a candidate for pharmaceutical applications. Its stereochemistry, indicated by the (5R) designation, implies specific spatial arrangements that can influence its reactivity and interaction with biological systems. The compound's solubility, stability, and pharmacokinetic properties would be essential for determining its efficacy and safety in therapeutic contexts. Overall, this substance represents a class of compounds that may exhibit significant pharmacological properties, warranting further investigation in drug development and related fields.

(5R)-6,7-Dihydro-4-[[trans-4-(4-morpholinyl)cyclohexyl]oxy]-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine-5-acetamide

1388894-17-4: The chemical substance known as (5R)-6,7-Dihydro-4-[[trans-4-(4-morpholinyl)cyclohexyl]oxy]-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine-5-acetamide, with the CAS number 1388894-17-4, is characterized by its complex molecular structure, which includes a thieno[2,3-d]pyrimidine core fused with a cyclopenta ring. This compound features a morpholine moiety, contributing to its potential biological activity, particularly in medicinal chemistry. The presence of the acetamide functional group suggests possible interactions with biological targets, making it a candidate for pharmaceutical applications. Its stereochemistry, indicated by the (5R) designation, implies specific spatial arrangements that can influence its reactivity and interaction with biological systems. The compound's solubility, stability, and pharmacokinetic properties would be essential for determining its efficacy and safety in therapeutic contexts. Overall, this substance represents a class of compounds that may exhibit significant pharmacological properties, warranting further investigation in drug development and related fields.

<p>ND-2110, a selective interleukin-1 receptor-associated kinase 4 inhibitors, is used for the treatment of autoimmune disorders and lymphoid malignancy.</p>

CAS 1388894-17-4

(5R)-6,7-Dihydro-4-[[trans-4-(4-morpholinyl)cyclohexyl]oxy]-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidine-5-acetamide

ND-2110

Ref: TM-T28143